Physostigmine - CalabarAlternative Names: Xalieve
Latest Information Update: 18 Jun 2015
At a glance
- Originator Calabar
- Class Alkaloids; Antidementias; Antidotes; Antiglaucomas; Phenylcarbamates; Small molecules; Smoking cessation therapies
- Mechanism of Action Cholinesterase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Xerostomia
Most Recent Events
- 01 Sep 2008 Phase-II clinical trials in Xerostomia in Sweden (PO)